The report provides a detailed analysis essential for establishing a Adefovir production plant. It encompasses all critical aspects necessary for Adefovir production, including the cost of Adefovir production, Adefovir plant cost, Adefovir production costs, and the overall Adefovir production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Adefovir production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Adefovir is a Nucleoside Reverse Transcriptase Inhibitor used to treat chronic hepatitis B viral infections. It belongs to the methylphosphonic acid class of phosphonic acids and acts as an inhibitor of HIV-1 reverse transcriptase. It functions as a nephrotoxic agent, an antiviral medication, a drug metabolite, an inhibitor of DNA synthesis, and an HIV-1 reverse transcriptase. It belongs to the ether family, the 6-aminopurine family, and the phosphonic acid family. It shares functionality with an adenine. Therefore, it finds its application in the pharmaceutical and medical industries.
The procurement of Adefovir is influenced by its application in the pharmaceutical and medical industries as an antiviral medication used to treat HIV and hepatitis B infections. The need for Adefovir is increasing as cases of Hepatitis B infections are on the rise. The increasing awareness among individuals towards Hepatitis B and antiviral therapy is also another factor that increases the need for Adefovir. Because of the improvement in health facilities, antiviral drugs are easily accessible to patients, and this has increased the options for patients.
Adefovir is used with other antiretroviral drugs in combination therapy to treat chronic hepatitis B, which increases its demand. It is available in oral tablet forms, which increases patient compliance. In general, the industrial Adefovir procurement is influenced by its application in the pharmaceutical and medical industries as an antiretroviral medication used in the treatment of chronic hepatitis B, the increasing number of hepatitis infection cases, its use with other antiretroviral drugs, combination therapy, the improvement of health facilities, raising awareness among individuals, cost-effectiveness, research and development, and regulatory approval.
Raw Material for Adefovir Production
According to the Adefovir production plant project report, the key raw material used in the production of Adefovir includes Adenine.
Manufacturing Process of Adefovir
The extensive Adefovir production cost report consists of the following major industrial production process:
- Production from Adenine: The production process of Adefovir begins with the alkylation of Adenine to form an alcohol intermediate. After that, this intermediate undergoes base-mediated alkylation with tosylate, which forms a phosphonate ester intermediate. Trimethylsilyl bromide (TMSBr) is used in the last step to dealkylate this intermediate to form Adefovir.
Adefovir, commercially known as Hepsera, is an off-white crystalline solid having the molecular formula C8H12N5O4P and a molecular weight of 273.19 g/mol. Its IUPAC name is 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid. It has a melting point of >250 °C. It has a water solubility of 2.02 mg/mL. The value of its log P is -1.8. The value of its dissociation constant, pKa, is 1.35, indicating that it is a strong acid. It releases harmful emissions of phosphorus and nitrogen oxides when heated to break down. Adefovir belongs to the methylphosphonic acid class of phosphonic acids, where a 2-(6-amino-9H-purin-9-yl)ethoxy group has taken the place of one of the methyl hydrogens. It is a Nucleoside Reverse Transcriptase Inhibitor used to treat chronic hepatitis B viral infections.
